Strategic Alliances Deemed Crucial To Neuroscience Firms' Success
Analysts warn that good marketing and sound financing are as key to survival for new ventures as top-notch science ST. LOUIS--After 20 years of vigorous scientific growth, neuroscience has vacated the biotechnology umbrella to emerge as a promising industry of its own. With an annual United States market of $4.4 billion in sales, neuropharmaceuticals is one area of biotechnology in which investors are always looking for a great deal. About two dozen startups are pursuing new technologies for d
Jan 20, 1991
Analysts warn that good marketing and sound financing are as key to survival for new ventures as top-notch science |
This tenuous position was illustrated here last fall in the space of a few hours and about a city block. When biologist J. Leslie Glick described his...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?